LeonaBio (LONA) Non-Current Assets (2019 - 2026)
LeonaBio's (LONA) quarterly Non-Current Assets came in at $2.4 million in Q1 2026, down 34.75% year-on-year from $3.7 million in Q1 2025, and down 11.33% on a QoQ basis from $2.7 million in Q4 2025.
LeonaBio (LONA) Non-Current Assets (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Non-Current Assets data on file, last reported at $2.4 million in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 34.75% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $11.4 million, a 30.35% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 31.62% from the prior year.
- Non-Current Assets for Q1 2026 stood at $2.4 million, down from $2.7 million in the prior quarter.
- Over the last five years, Non-Current Assets for LONA reached as high as $50.6 million in Q4 2022 and fell as low as $2.4 million in Q1 2026.
- Historically, Non-Current Assets has averaged $16.2 million across 5 years, with a median of $4.8 million in 2024.
- On a YoY basis, Non-Current Assets climbed as much as 9.06% in 2023 and fell as far as 89.1% in 2023.
- Year by year, Non-Current Assets stood at $50.6 million in 2022, then sank by 89.1% to $5.5 million in 2023, then decreased by 28.61% to $3.9 million in 2024, then sank by 31.62% to $2.7 million in 2025, then fell by 11.33% to $2.4 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $2.4 million in Q1 2026, $2.7 million in Q4 2025, and $3.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 5.83 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.95 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 285.82 Mn |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - | 2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | 2.69 Mn |
| Sep 30, 2025 | 3.01 Mn |
| Jun 30, 2025 | 3.33 Mn |
| Mar 31, 2025 | 3.66 Mn |
| Dec 31, 2024 | 3.94 Mn |
| Sep 30, 2024 | 4.24 Mn |
| Jun 30, 2024 | 4.55 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Dec 31, 2023 | 5.52 Mn |
| Sep 30, 2023 | 6.20 Mn |
| Jun 30, 2023 | 15.92 Mn |
| Mar 31, 2023 | 39.88 Mn |
| Dec 31, 2022 | 50.62 Mn |
| Sep 30, 2022 | 45.21 Mn |
| Jun 30, 2022 | 36.15 Mn |
| Mar 31, 2022 | 43.85 Mn |
| Dec 31, 2021 | 71.21 Mn |
| Sep 30, 2021 | 108.34 Mn |
| Jun 30, 2021 | 69.63 Mn |